HIPAA APCM Compliance for Allergy & Immunology

Ensure all AI-driven voice interactions regarding inhaler technique or asthma symptoms are encrypted using AES-256 standards during transit and at rest.

Configure AI call handling systems to automatically redact unnecessary PHI from transcripts of immunotherapy reminder calls.

Require MFA for all allergy practice staff accessing the APCM dashboard and patient communication logs.

Maintain detailed logs of every instance an AI system or staff member accesses a patient's asthma action plan or eczema management history.

Verify that any automated SMS reminders for epinephrine or biologic refills are sent through HIPAA-compliant gateways.

Verify that a signed BAA is in place with the AI call center provider and any vendors handling immunotherapy data.

Conduct specialized HIPAA training for clinical staff focusing on APCM documentation for chronic urticaria and immunodeficiency.

Perform a yearly risk analysis of all remote monitoring tools used to track peak flow or inhaler usage for asthma patients.

Align AI data retention settings with AAAAI practice guidelines for long-term immunotherapy and IVIG records.

Develop a specific protocol for notifying patients if their chronic care management data is compromised.

Capture and document verbal or written consent for APCM enrollment, specifically mentioning the use of AI for follow-up calls.

Ensure the practice's Notice of Privacy Practices specifically mentions the use of third-party AI tools for chronic care management.

Establish a secure method for patients to request and receive copies of their AI-managed care plans and call histories.

Provide clear mechanisms for patients to opt-out of automated immunotherapy maintenance reminders without losing access to care.

Program the AI call handler to verify at least two patient identifiers before discussing asthma symptoms or biologic dosages.